XML 50 R21.htm IDEA: XBRL DOCUMENT v2.4.0.8
Equity-Based Compensation (Tables)
3 Months Ended
Mar. 29, 2014
Equity-Based Compensation [Abstract]  
Schedule Of Remaining Unrecognized Compensation Expense For Unvested Awards

 

 

 

 

 

 

2014

 

$          6,784

2015

 

7,299 

2016

 

5,420 

2017

 

3,348 

2018

 

541 

 

 

$        23,392

 

 

 

The cost above is expected to be recognized over a weighted-average

 

 

period of 2.2 years.

 

 

 

Schedule Of Fair Value Assumptions

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

March 30,

 

March 29,

 

 

2013

 

2014

 

 

 

 

 

Expected volatility (1) .

 

43.7% 

 

39.9% 

Risk-free interest rate (2) .

 

0.6% 

 

1.2% 

Expected life (3) .

 

3.97 yrs

 

3.54 yrs

Expected dividend yield (4) .

 

0.0% 

 

0.0% 

Weighted-average exercise price (5) .

 

$
38.69 

 

$
57.62 

 

 

 

 

 

(1) The Company utilizes historical volatility of the trading price of its common stock.

(2) Risk-free interest rate is based on the U.S. Treasury yield curve with respect to the expected life of

the award.

 

 

 

 

(3) Depending upon the terms of the award, expected life may be a weighted-average that includes

 historical settlement data of the Company's equity awards and a hypothetical holding

 period for outstanding awards, or it may be calculated under the simplified method.

(4) The Company historically has not paid dividends.

(5) Exercise price is the closing price of the Company's common stock on the date of grant.

 

 

 

 

 

 

 

 

Schedule Of Stock Option Activity

 

 

 

 

 

 

 

 

 

 

 

 

Shares

 

Weighted-average exercise price

 

Weighted-average remaining contractual term

 

Aggregate intrinsic value*

 

Outstanding at December 28, 2013

 

1,827 

 

$          37.37

 

2.6 

 

$        74,160

 

Granted

 

669 

 

57.62 

 

 

 

 

 

Exercised

 

(160)

 

28.83 

 

 

 

 

 

Forfeited

 

(20)

 

27.33 

 

 

 

 

 

Expired

 

 -

 

 -

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at March 29, 2014

 

2,316 

 

$          43.90

 

3.0 

 

$        70,387

 

 

 

 

 

 

 

 

 

 

 

Exercisable at March 29, 2014

 

424 

 

$          37.96

 

1.9 

 

$        15,280

 

 

 

 

 

 

 

 

 

 

 

* Aggregate intrinsic value is defined as the difference between the current market value at the reporting date (the closing price of the

 

Company's common stock on the last trading day of the period) and the exercise price of awards that were in-the- money.  The

 

closing price of the Company's common stock at December 28, 2013, and March 29, 2014, was $77.72 and $74.02, respectively.